Foto de portada de Almirall
Almirall

Almirall

Fabricación de productos farmacéuticos

Sobre nosotros

Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).

Sitio web
http://www.almirall.com
Sector
Fabricación de productos farmacéuticos
Tamaño de la empresa
De 1.001 a 5.000 empleados
Sede
Barcelona
Tipo
Empresa pública
Especialidades
Dermatology (Actinic keratosis, Atopic Dermatitis, Eczema, Inflammatory Skin Conditions, Psoriasis, Rosacea, Severe Acne), OTC Products, Other Specialty Areas (e.g. Spasticity in Multiple Sclerosis) y Medical Device

Ubicaciones

  • Principal

    Ronda General Mitre, 151

    Barcelona, 08022, ES

    Cómo llegar
  • Carretera Laureà Miró, 408

    Sant Feliu de Llobregat, Barcelona 08980, ES

    Cómo llegar
  • Carretera de Martorell 41-61

    Sant Andreu de la Barca, Barcelona 08740 , ES

    Cómo llegar

Empleados en Almirall

Actualizaciones

  • 📈 Almirall's H1 2025 financial results reflect the company’s sustained growth trajectory, aligned with our mission to transform patients' lives. Our strong performance in the first half of the year, driven by key contributions from across our portfolio, enables us to continue investing in groundbreaking research and development, accelerating the delivery of new and impactful treatments for people living with skin conditions. We are immensely proud of what we are building together – a future where we deliver impactful medicines for more patients in medical dermatology.✨ #WeAreAlmirall #MedicalDermatology

  • Ver la página de empresa de Almirall

    151.291 seguidores

    📢 We are excited to announce the expansion of our AI Drug Creation collaboration with Absci, marking a new milestone in our shared commitment to accelerate innovation in dermatology. This partnership combines Almirall's deep dermatology expertise with Absci's cutting-edge generative AI platform to unlock new therapeutic approaches.  We are proud to be at the forefront of science, working to explore the newest technological advances to improve unmet needs of dermatological patients. #WeAreAlmirall #AIDrugDiscovery #Dermatology #Innovation

  • Ver la página de empresa de Almirall

    151.291 seguidores

    ☀ #ActinicKeratosis (AK) is one of the most common precancerous skin conditions—and it’s preventable with the right awareness and care. At Almirall, our work is driven by a simple but powerful purpose: to transform patients’ lives. That's why we are committed to supporting patients through education and early detection because together, we can protect our skin’s memories and build a future where fewer people are affected by preventable skin conditions. Swipe through to learn more about the UV Index and let's keep raising awareness about the importance of protecting our skin! #WeAreAlmirall #AKGlobalDay

  • 🔔 Almirall has achieved strong results in the first half of 2025, marking another period of consistent progress. This performance is a testament to our focus on operational excellence and the positive evolution across our portfolio. It allows us to reiterate our full-year guidance and continue our sustainable growth trajectory. We're excited about the future and our continued leadership in medical dermatology. 📈 Slide to discover more about our H1 financial results. #WeAreAlmirall #FinancialResults 

  • Ver la página de empresa de Almirall

    151.291 seguidores

    🌱 We’re proud to share that Almirall has once again been awarded the EcoVadis Platinum Medal, with a remarkable score of 92/100 — placing us in the top 1% of all rated companies globally. Progress across key dimensions: ▪️ Environment: 98/100 — earning Leader status in Carbon Management ▪️ Labour & Human Rights: 91/100 ▪️ Ethics: 84/100 ▪️ Sustainable Procurement: 89/100 Our journey reflects deep-rooted commitment across the organisation — driven by our Act4Impact Sustainability Strategy, ambitious sustainability-related goals, and the passionate collaboration of our teams. 👏 Thank you to everyone who made this possible. Together, we’re shaping a more sustainable future for patients, society, and the planet. #WeAreAlmirall #Sustainability #EcoVadis #Act4Impact

  • ✨Sanctuary Salons are redefining what it means to feel safe, seen, and supported in everyday spaces. For individuals living with scalp-related skin conditions—such as psoriasis, atopic dermatitis, or actinic keratosis—a visit to the hair salon can often come with feelings of discomfort, guilt, or fear. We believe that should never be the case. Sanctuary Salons are designed to be welcoming environments where people can speak openly about their experiences and feel confident receiving care without judgment. Because everyone deserves the chance to enjoy a fresh haircut, embrace a new look, and feel beautiful. At Almirall, we’re proud to help open these doors—creating spaces where empathy meets expertise. 🔗 Find your nearest Sanctuary Salon at https://lnkd.in/dh_C9gis #SanctuarySalon #WeAreAlmirall

  • Celebrating science, innovation, and the leaders of tomorrow. 🔬 At Almirall, we believe that innovation doesn’t happen in isolation—it thrives through collaboration and the bold ideas of emerging scientific leaders. That’s why we were proud to present the Almirall award at the XXI National Meeting of the Sociedad Española de Química Terapéutica (SEQT) Andrea Bertran, PhD, for her outstanding research: a powerful example of science pushing boundaries. This recognition is more than a prize. It's part of our ongoing commitment to support the next generation of researchers who are shaping the future of healthcare. Let’s keep building a future where innovation, inclusion, and collaboration go hand in hand! #Collaboration #Innovation #WeAreAlmirall

    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
  • ☀️ Sun exposure is a daily reality—not just something that happens at the beach. Even on cloudy days or during your morning commute, UV rays can silently damage your skin. That’s why incorporating sunscreen into your daily routine is essential. Regular use of sunscreen can reduce your risk of developing actinic keratosis by up to 40%, a common precancerous skin condition linked to sun exposure. Your skin is with you for life—protect it well so you can enjoy every moment with confidence. #AKGlobalDay #WeAreAlmirall

  • 🚀Inspiring the next generation of global leaders starts with open dialogue, and we were delighted to recently host a group of MBA International students from the Universidad Peruana de Ciencias Aplicadas (UPCA) at our Sant Andreu de la Barca facilities. The visit was a valuable opportunity to exchange ideas on how digital and business transformation is reshaping industries worldwide. Through a dynamic session covering innovation, internationalization, and evolving market ecosystems, we explored both the successes and challenges that come with driving change. 🤝 We remain committed to fostering collaboration across borders and generations, and to contributing to the development of future leaders who will shape the next chapter of our industry. #Collaboration #WeAreAlmirall Francesc Catalan Jesus Tomé Pol Salvadó Cols Marc Perez Puigdengoles

    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
  • 📍During ICD 2025 Rome, the project #PsOver was announced as the selected proposal for this first edition of the #PsOlve challenge. Looking back on this incredible journey, you can now relive the energy, creativity, and commitment of that day through this recap video. Hear from the jury about their experience with PsOlve, the collaboration it enabled, the innovation it fostered, and why they believe you should be part of future challenges. 🎥 Watch the video and experience the impact of the Pitch Day! #WeAreAlmirall #Collaboration #Innovation

Páginas similares

Buscar empleos

Financiación

Almirall 1 ronda en total

Última ronda

Equidad tras OPV

215.250.498,00 US$

Ver más información en Crunchbase